Comments

Sarepta Therapeutics

Q: What sector and industry does Sarepta Therapeutics (SRPT) operate in?

Sarepta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

SRPTNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$127.08

2.832.28%

At close: -

$127.08

00.00%

After Hours: 6:27 PM EDT

15 minutes delayed

Sarepta Therapeutics (SRPT) Forecast

News Earnings Sarepta Therapeutics (SRPT) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Overview Rating

Speculative

Technicals Analysis

100

0100

Financials Analysis

0100

Sarepta Therapeutics (NASDAQ:SRPT) Stock Quotes, Forecast and News Summary

Sarepta Therapeutics Stock (NASDAQ: SRPT) stock price, news, charts, stock research, profile.

Open	$124.98
Close	$127.08
Volume / Avg.	1.03M / 964.98K
Day Range	$124.26 - $130.04
52 Wk Range	55.25 - 173.25
Market Cap	$12.12B
P/E Ratio	165.67
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	6.78%
Days to Cover	9.1

Recent News

After US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of Catalent

Public interest groups are urging the FTC to block Novo Holdings' $16.5 billion acquisition of Catalent, citing concerns over reduced competition in critical areas like diabetes, obesity treatments, and gene therapy.

Vandana Singh

Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher

Capricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like Duchenne muscular dystrophy (DMD).

MarketBeat

Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular Dystrophy

Dyne Therapeutics revealed new clinical data from its Phase 1/2 DELIVER trial of DYNE-251 for Duchenne muscular dystrophy, showing significant increases in dystrophin expression and meaningful functional improvements.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Sep

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$124.98
Close	$127.08
Volume / Avg.	1.03M / 964.98K
Day Range	$124.26 - $130.04
52 Wk Range	55.25 - 173.25
Market Cap	$12.12B
P/E Ratio	165.67
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	6.78%
Days to Cover	9.1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Sarepta Therapeutics (SRPT) stock?

You can purchase shares of Sarepta Therapeutics (NASDAQ:SRPT) through any online brokerage.

View our list of the best stock brokerages

Who are Sarepta Therapeutics (SRPT) competitors?

Other companies in Sarepta Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Sarepta Therapeutics (SRPT) stock?

Sarepta Therapeutics has a consensus price target of $183.04.

What is the current price for Sarepta Therapeutics (SRPT)?

The stock price for Sarepta Therapeutics (NASDAQ: SRPT) is $127.08 last updated October 18, 2024 at 6:27 PM EDT.

Does Sarepta Therapeutics (SRPT) pay a dividend?

There are no upcoming dividends for Sarepta Therapeutics.

When is Sarepta Therapeutics (NASDAQ:SRPT) reporting earnings?

Sarepta Therapeutics’s Q3 earnings are confirmed for Wednesday, October 30, 2024.

Is Sarepta Therapeutics (SRPT) going to split?

There is no upcoming split for Sarepta Therapeutics.

What sector and industry does Sarepta Therapeutics (SRPT) operate in?

Sarepta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.